• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于耐受性调节的白细胞介素 10 工程化树突状细胞治疗,以恢复 T 细胞介导疾病中的抗原特异性耐受性。

Tolerogenic IL-10-engineered dendritic cell-based therapy to restore antigen-specific tolerance in T cell mediated diseases.

机构信息

Mechanisms of Peripheral Tolerance Unit, San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Via Olgettina 60, 20132, Milan, Italy.

Mechanisms of Peripheral Tolerance Unit, San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Via Olgettina 60, 20132, Milan, Italy; University of Rome Tor Vergata, Via Cracovia 50, 00133, Rome, Italy.

出版信息

J Autoimmun. 2023 Jul;138:103051. doi: 10.1016/j.jaut.2023.103051. Epub 2023 May 22.

DOI:10.1016/j.jaut.2023.103051
PMID:37224733
Abstract

Tolerogenic dendritic cells play a critical role in promoting antigen-specific tolerance via dampening of T cell responses, induction of pathogenic T cell exhaustion and antigen-specific regulatory T cells. Here we efficiently generate tolerogenic dendritic cells by genetic engineering of monocytes with lentiviral vectors co-encoding for immunodominant antigen-derived peptides and IL-10. These transduced dendritic cells (designated DC) secrete IL-10 and efficiently downregulate antigen-specific CD4 and CD8 T cell responses from healthy subjects and celiac disease patients in vitro. In addition, DC induce antigen-specific CD49bLAG-3 T cells, which display the T regulatory type 1 (Tr1) cell gene signature. Administration of DC resulted in the induction of antigen-specific Tr1 cells in chimeric transplanted mice and the prevention of type 1 diabetes in pre-clinical disease models. Subsequent transfer of these antigen-specific T cells completely prevented type 1 diabetes development. Collectively these data indicate that DC represent a platform to induce stable antigen-specific tolerance to control T-cell mediated diseases.

摘要

耐受性树突状细胞通过抑制 T 细胞反应、诱导致病性 T 细胞耗竭和抗原特异性调节性 T 细胞,在促进抗原特异性耐受中发挥关键作用。在这里,我们通过慢病毒载体共转染单核细胞,高效地生成了具有免疫显性抗原衍生肽和 IL-10 的基因工程耐受性树突状细胞(命名为 DC)。这些转导的树突状细胞(DC)分泌 IL-10,并有效地下调来自健康供体和乳糜泻患者的抗原特异性 CD4 和 CD8 T 细胞反应。此外,DC 诱导抗原特异性 CD49bLAG-3 T 细胞,其显示 T 调节型 1(Tr1)细胞基因特征。在嵌合移植小鼠中,给予 DC 导致抗原特异性 Tr1 细胞的诱导,并在临床前疾病模型中预防 1 型糖尿病。随后转移这些抗原特异性 T 细胞完全阻止了 1 型糖尿病的发展。总的来说,这些数据表明,DC 代表了诱导稳定的抗原特异性耐受以控制 T 细胞介导的疾病的平台。

相似文献

1
Tolerogenic IL-10-engineered dendritic cell-based therapy to restore antigen-specific tolerance in T cell mediated diseases.基于耐受性调节的白细胞介素 10 工程化树突状细胞治疗,以恢复 T 细胞介导疾病中的抗原特异性耐受性。
J Autoimmun. 2023 Jul;138:103051. doi: 10.1016/j.jaut.2023.103051. Epub 2023 May 22.
2
APVO210: A Bispecific Anti-CD86-IL-10 Fusion Protein (ADAPTIR™) to Induce Antigen-Specific T Regulatory Type 1 Cells.APVO210:一种双特异性抗 CD86-IL-10 融合蛋白(ADAPTIR™),可诱导抗原特异性 T 调节型 1 细胞。
Front Immunol. 2018 May 25;9:881. doi: 10.3389/fimmu.2018.00881. eCollection 2018.
3
Interleukin-10 Gene-Modified Dendritic Cell-Induced Type 1 Regulatory T Cells Induce Transplant-Tolerance and Impede Graft Versus Host Disease After Allogeneic Stem Cell Transplantation.白细胞介素-10基因修饰的树突状细胞诱导的1型调节性T细胞可诱导移植耐受并抑制异基因干细胞移植后的移植物抗宿主病。
Cell Physiol Biochem. 2017;43(1):353-366. doi: 10.1159/000480415. Epub 2017 Aug 31.
4
Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway.1 型调节性 T 细胞(Tr1)的分化由耐受型 DC-10 通过依赖于 IL-10 的 ILT4/HLA-G 途径实现。
Blood. 2010 Aug 12;116(6):935-44. doi: 10.1182/blood-2009-07-234872. Epub 2010 May 6.
5
Engineered T Regulatory Type 1 Cells for Clinical Application.工程化调节性 T 细胞 1 型用于临床应用。
Front Immunol. 2018 Feb 15;9:233. doi: 10.3389/fimmu.2018.00233. eCollection 2018.
6
Interleukin-10-Producing DC-10 Is a Unique Tool to Promote Tolerance Antigen-Specific T Regulatory Type 1 Cells.白细胞介素-10 分泌型树突状细胞-10 是一种独特的工具,可促进耐受抗原特异性 T 调节型 1 细胞。
Front Immunol. 2018 Apr 6;9:682. doi: 10.3389/fimmu.2018.00682. eCollection 2018.
7
Cisplatin induces tolerogenic dendritic cells in response to TLR agonists via the abundant production of IL-10, thereby promoting Th2- and Tr1-biased T-cell immunity.顺铂通过大量产生白细胞介素-10对Toll样受体激动剂作出反应,诱导产生耐受性树突状细胞,从而促进偏向于辅助性T细胞2型和1型调节性T细胞的免疫反应。
Oncotarget. 2016 Jun 7;7(23):33765-82. doi: 10.18632/oncotarget.9260.
8
IL-10-Engineered Dendritic Cells Modulate Allogeneic CD8 T Cell Responses.IL-10 工程化树突状细胞调节同种异体 CD8 T 细胞反应。
Int J Mol Sci. 2023 May 23;24(11):9128. doi: 10.3390/ijms24119128.
9
Generation of Powerful Human Tolerogenic Dendritic Cells by Lentiviral-Mediated IL-10 Gene Transfer.通过慢病毒介导的 IL-10 基因转移生成功能强大的人源耐受性树突状细胞。
Front Immunol. 2020 Jun 30;11:1260. doi: 10.3389/fimmu.2020.01260. eCollection 2020.
10
Dendritic cells genetically engineered to express IL-10 induce long-lasting antigen-specific tolerance in experimental asthma.经基因工程改造以表达白细胞介素-10的树突状细胞可在实验性哮喘中诱导持久的抗原特异性耐受性。
J Immunol. 2008 Nov 15;181(10):7230-42. doi: 10.4049/jimmunol.181.10.7230.

引用本文的文献

1
Armored human CAR T cells with PD1 promoter-driven IL-10 have enhanced suppressive function.具有PD1启动子驱动的IL-10的装甲人类嵌合抗原受体T细胞具有增强的抑制功能。
Sci Adv. 2025 Jun 13;11(24):eadx7845. doi: 10.1126/sciadv.adx7845.
2
Advances in Regulatory Cell Therapy for Type 1 Diabetes: Emerging Strategies and Future Directions.1型糖尿病调节性细胞疗法的进展:新兴策略与未来方向
Eur J Immunol. 2025 May;55(5):e202451722. doi: 10.1002/eji.202451722.
3
Extracellular vesicles from human semen induce unique tolerogenic phenotypes in vaginal dendritic cells and regulatory T lymphocytes.
来自人类精液的细胞外囊泡在阴道树突状细胞和调节性T淋巴细胞中诱导独特的致耐受性表型。
Front Immunol. 2025 May 12;16:1564002. doi: 10.3389/fimmu.2025.1564002. eCollection 2025.
4
In vivo armed macrophages curb liver metastasis through tumor-reactive T-cell rejuvenation.体内武装巨噬细胞通过肿瘤反应性T细胞复苏抑制肝转移。
Nat Commun. 2025 Apr 11;16(1):3471. doi: 10.1038/s41467-025-58369-2.
5
Investigating the therapeutic potential of tryptophan and vitamin A in modulating immune responses in celiac disease: an experimental study.研究色氨酸和维生素A在调节乳糜泻免疫反应中的治疗潜力:一项实验研究。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr 3. doi: 10.1007/s00210-025-04089-9.
6
A comprehensive overview of tolerogenic vaccine adjuvants and their modes of action.耐受性疫苗佐剂及其作用方式的全面概述。
Front Immunol. 2024 Dec 20;15:1494499. doi: 10.3389/fimmu.2024.1494499. eCollection 2024.
7
Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders.自身免疫性疾病的自身免疫机制演变和新的治疗策略。
Signal Transduct Target Ther. 2024 Oct 4;9(1):263. doi: 10.1038/s41392-024-01952-8.
8
Leveraging current insights on IL-10-producing dendritic cells for developing effective immunotherapeutic approaches.利用当前对产生白细胞介素-10的树突状细胞的见解来开发有效的免疫治疗方法。
FEBS Lett. 2024 Sep 12. doi: 10.1002/1873-3468.15017.
9
MerTK Induces Dysfunctional Dendritic Cells by Metabolic Reprogramming.MerTK 通过代谢重编程诱导功能失调的树突状细胞。
Cancer Immunol Res. 2024 Sep 3;12(9):1268-1285. doi: 10.1158/2326-6066.CIR-23-0666.
10
Development Perspectives for Curative Technologies in Primary Demyelinating Disorders of the Central Nervous System with Neuromyelitis Optica Spectrum Disorder (NMOSD) and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) at the Forefront.以视神经脊髓炎谱系障碍(NMOSD)和髓鞘少突胶质细胞糖蛋白抗体相关疾病(MOGAD)为前沿的中枢神经系统原发性脱髓鞘疾病治疗技术的发展前景。
J Pers Med. 2024 Jun 4;14(6):599. doi: 10.3390/jpm14060599.